+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Beneficial effect of risedronate on arterial thickening and stiffening with a reciprocal relationship to its effect on bone mass in female osteoporosis patients: a longitudinal study



Beneficial effect of risedronate on arterial thickening and stiffening with a reciprocal relationship to its effect on bone mass in female osteoporosis patients: a longitudinal study



Life Sciences 87(23-26): 686-691



A longitudinal study was performed to examine the effect of risedronate on arterial thickening and stiffening in postmenopausal female osteoporosis patients. Patients treated with risedronate (2.5mg/day) (n=33) and those that did not receive risedronate (n=30, control group) were monitored over a 1-year period. Bone metabolic markers, bone mineral density (BMD) of the femur neck (FN), brachial-ankle pulse wave velocity (baPWV), and intima-media thickness at the carotid artery (CA-IMT) were measured. At baseline, there was no significant difference in blood pressure, serum lipid profiles, FN BMD, baPWV and CA-IMT between the risedronate-treated patients and the controls. Baseline levels of FN BMD were significantly negatively correlated with those of CA-IMT and baPWV. During the study, FN BMD increased significantly in the risedronate group (p=0.0097), but decreased significantly in the control group (p=0.0013). BaPWV and CA-IMT did not change significantly in the risedronate group, but both increased significantly in the control group. The percentage change in FN BMD over the study period showed a significant negative correlation with those for baPWV (r=-0.294, p=0.0262) and CA-IMT (r=-0.305, p=0.0234) in all subjects (risedronate-treated patients and controls). In addition to increasing BMD, risedronate significantly suppressed the progression of arterial thickening and stiffening in postmenopausal osteoporotic patients over one year. These changes may indirectly be due to the effect of risedronate on bone.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051772099

Download citation: RISBibTeXText

PMID: 20951147

DOI: 10.1016/j.lfs.2010.10.006


Related references

Arterial stiffening is a heritable trait associated with arterial dilation but not wall thickening: a longitudinal study in the twins UK cohort. European Heart Journal 39(24): 2282-2288, 2018

Bone Mass Outcomes in Patients With Osteoporosis Treated With Risedronate After Alendronate Failure: a 12-Month Follow-Up Study. Journal of Clinical Densitometry 20(1): 44-49, 2016

A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients. Rheumatology 46(2): 257-264, 2007

Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats: a bone histomorphometry study. Journal of Nutritional Science and Vitaminology 52(5): 307-315, 2006

Effect of distal thickening and stiffening of plaque cap on arterial wall mechanics. Medical and Biological Engineering and Computing 56(11): 2003-2013, 2018

Increases in central fat mass and decreases in peripheral fat mass are associated with accelerated arterial stiffening in healthy adults: the Amsterdam Growth and Health Longitudinal Study. American Journal of Clinical Nutrition 94(1): 40-48, 2011

Effects of Risedronate on bone mass in an animal model of male osteoporosis DXA study. Journal of Bone & Mineral Research 15(Suppl 1): S432, 2000

A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial. Osteoporosis International 13(12): 971-979, 2002

Effect of Combined Teriparatide and Monthly Risedronate Therapy on Cancellous Bone Mass in Orchidectomized Rats: A Bone Histomorphometry Study. Calcified Tissue International 97(1): 23-31, 2015

Effect of rectal salmon calcitonin treatment on bone mass and bone turnover in patients with established postmenopausal osteoporosis: A-year crossover study. Current Therapeutic Research 54(4): 458-465, 1993

Effect of once weekly Risedronate on bone density in postmenopausal osteoporosis. Journal of Bone & Mineral Research 16(Suppl 1): S286, 2001

Methylprednisolone has a preventive effect on heterotopic bone formation and on knee thickening and stiffening following manipulation of immobilized rabbit legs. Clinical and Experimental Rheumatology 12(4): 409-413, 1994

Arterial stiffening and thickening in patients with pseudoxanthoma elasticum. Atherosclerosis 270: 160-165, 2018

Arterial stiffening and thickening in patients with pseudoxanthoma elasticum. Atherosclerosis 270: 160-165, 2018

A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase II Research Group). Osteoporosis International 14(3): 225-234, 2003